Comparison of high‐intensity interval training and moderate‐intensity continuous training on cardiopulmonary function, cardiac autonomic function and vascular function in adolescent boys with obesity: A randomized controlled trial Authors: Zheng‐yu Su, Wei‐liang Yu, Zhi‐wei Yan, Duo‐duo Ding, Chang‐chang Fang, Qing‐lu Luo, Xiao Liu, Lian‐Zhong Cao Published: 2024 ABSTRACT AbstractAdolescent obesity can impair cardiopulmonary function, vascular elasticity, endothelial function, and vago‐sympathetic balance. While moderate‐intensity continuous training (MICT) benefits cardiovascular health in obese adolescents, the effects of high‐intensity interval training (HIIT) are less understood. We hypothesize that HIIT may be more effective than MICT in improving VO2peak, vascular elasticity, endothelial function, and vago‐sympathetic balance in obese adolescent boys. Forty four participants were randomly assigned to the HIIT (10 × 1‐min at 85%–95% peak HR, intersperse with 2‐min active recovery at 60%–70% peak HR) or MICT (35 min at 65%–75% peak HR) for an 8‐week program. The primary outcome measured was the change in VO2peak with secondary outcomes including brachial‐ankle pulse wave velocity (baPWV), flow‐mediated dilation (FMD), and heart rate variability (HRV). Forty four adolescent boys with obesity (age, 14 ± 1 years old, body mass index, 31.6 ± 1.3 kg/m2) were enrolled and 43 (97.73%) completed the 8‐week exercise. No significant difference of VO2peak was found between the HIIT and MICT group (p = 0.243). There was no significant difference of baPWV between the groups (p = 0.789). Change in FMD% was significantly higher in the HIIT group compared to the MICT group (p < 0.001). The Change in HRV‐high frequency (HRV‐HF; p = 0.009) and HRV‐low frequency/high frequency (HRV‐LF/HF; p = 0.035) was significantly higher in the HIIT group compared to the MICT group. Among adolescent boys with obesity, 8‐week HIIT and MICT had similar effects on improving VO2peak. HIIT may be superior to MICT to improve endothelial function and vago‐sympathetic balance. INTRODUCTION Obesity poses a substantial risk for cardiovascular and metabolic conditions and continues to be a leading contributor to chronic disease risk worldwide (Malone & Hansen, 2019). Alarmingly, an increasing number of children and adolescents are falling into overweight or obese (Sommer & Twig, 2018; WHO, June 2021). Preventing and managing obesity among adolescents is a critical global public health initiative aimed at curbing the potential for cardiovascular and metabolic diseases in adulthood (Sommer & Twig, 2018). Obesity in adolescents leads to endothelial dysfunction, vascular stiffness, and autonomic nervous system imbalance, which contribute to widespread endogenous stress on the cardiovascular system through mechanisms such as lipid metabolism disruption, insulin resistance, and inflammation (Cozzolino et al., 2014; Dangardt et al., 2013; Freitas et al., 2014; Murni et al., 2020). Autonomic dysfunction characterized by sympathetic‐vagal imbalance is a significant underlying mechanism in the development of cardiovascular diseases (Freitas et al., 2014), potentially linked to reduced reflex sensitivity and disrupted circadian rhythms of the cardiac autonomic function (Lazarova et al., 2009; Rodríguez‐Colón et al., 2014). These multifactorial issues significantly elevate the cardiovascular disease risk in obese adolescents as they transition into adulthood (Sommer & Twig, 2018). Previous research also suggests that autonomic imbalance contributes to reduced cardiorespiratory fitness in obese adolescents, indicating a potential attenuation in the interplay between cardiovascular and respiratory systems (Campos et al., 2022). Therefore, recognizing the pivotal role of cardiorespiratory health in predicting cardiovascular risk underscores the increasing awareness for early and targeted preventive interventions in obese adolescents (da Silva et al., 2014; Redón et al., 2017). On the other hand, exercise offers a broad spectrum of cardiovascular protective benefits and operates through various pathways, triggering both direct and indirect endogenous protective mechanisms (Valenzuela et al., 2023; Yan et al., 2022). Moderate‐Intensity Continuous Training (MICT) is strongly associated with cardiovascular well‐being, as it bestows cardiovascular protective advantages by enhancing cardiorespiratory function, mitigating vascular dysfunction, and fostering a balanced cardiac autonomic system in adolescents with obesity (Alberga et al., 2016; Chen et al., 2016; Watts et al., 2004). High‐Intensity Interval Training (HIIT) is a training method that involves alternating short bursts of high‐intensity exercise with periods of rest or lower‐intensity exercise (Taylor et al., 2019). While emerging studies have indicated that HIIT may be more effective in enhancing cardiometabolic health, cardiorespiratory function, and weight management in adolescents with obesity compared with MICT, it is important to note that conflicting findings persist (Martin‐Smith et al., 2020; Miguet et al., 2020; Morrissey et al., 2018). Furthermore, investigations into the impact of HIIT and MICT on cardiac autonomic function and vascular health have predominantly centered on adults populations. There is a noticeable dearth of research into the potential of HIIT and MICT to mitigate cardiac autonomic dysfunction, endothelial dysfunction, and vascular stiffness in adolescents with obesity (de Oliveira et al., 2020; Nie et al., 2018; van Biljon et al., 2018). Given this background, the objective of this randomized controlled trial was to compare the HIIT and MICT on cardiopulmonary function in adolescents with obesity. We hypothesized that HIIT may be superior to MICT in improving cardiopulmonary function, cardiac autonomic function, endothelial function, and vascular elasticity in adolescent boys with obesity when matched with an equivalent workload. MATERIALS & METHODS Research design This was an assessor‐blind, two‐arm, parallel randomized controlled trial. An overview of the trial procedures could be seen in Figure 1. The study protocol received approval from the Ethics Committee of Shenyang Sport University and adhered to the principles outlined in the Declaration of Helsinki. The trial was registered on the Clinical Trial Registry (ChiCTR2300070813). Prior to enrollment, all boys provided written informed consent (with the consent of their guardian), and the study's findings were reported in accordance with the Consolidated Standards of Reporting Trials guidelines. Patient recruitment, randomization, and follow‐up in the 8‐week intervention. Research setting We recruited 44 adolescent boys with obesity from a weight loss camp in Shenyang, China from April to July in 2023. Adolescent boys with obesity are those whose body mass index (BMI) for their age is two standard deviations above the median or higher (“[Expert Consensus on Obesity Prevention and Treatment in China],” 2022). The diagnosis of obesity was made by an exercise physiologist. The exercise interventions and the assessment of anthropometric measurements and physiological indicators were conducted within the weight loss camp. Our research personnel, who were unaware of the participants' group assignments, were responsible for gathering baseline data, overseeing the training sessions, and conducting tests related to clinical exercise physiology outcomes. Inclusion criteria Participants were considered eligible based on both of the following criteria: (1) Meeting the WHO Growth Reference for adolescent boys with obesity, which was defined as those whose BMI for age that exceeded two standard deviations above the median (" [Expert Consensus on Obesity Prevention and Treatment in China]," 2022); (2) Not engaging in a regular exercise for at least 6 months prior to the commencement of the exercise program; (3) Voluntarily participating in the exercise intervention; and (4) Providing a signed informed consent form (parental consent). Exclusion criteria Participants who met any of the following criteria would be excluded from the study: (1) Engagement in other regular physical activities or training; and (2) Self‐reported history of metabolic, endocrine, orthopedic, or cardiovascular diseases and the use of prescribed medications. Random assignment and blinding Following the initial baseline assessment, the participants were randomly allocated into the HIIT group and MICT group in a 1:1 ratio. This study was conducted as an assessor‐blind randomized controlled trial, with measurements taken at baseline and after 8 weeks by assessors who were unaware of the participants' group assignments. The interventions were administered by the study staff. The randomization table was generated by the Department of Statistics at the School of Public Health, Fudan University, using Microsoft Excel software. The study staff, who remained unaware of the group allocations, collected the measurements and maintained possession of the randomization table. The group assignments for each participant were sealed in opaque envelopes and were only revealed after the completion of the baseline assessments. Sample size calculation A statistical power of 0.95 and an alpha level of 0.05 with one side were employed. As determined from a meta‐analysis, a mean (SD) difference in the change of peak VO2 of 1.3 (1.1) mL/kg/min between HIIT and MICT was assumed (Cao et al., 2021). The minimum required sample size of 17 for each group was calculated. To account for a potential dropout rate of 20%, 22 participants per group (44 total) were recruited. The sample size was established using PASS 15 software (NCSS Corp.). Intervention Following the completion of informed consent and screening procedures, participants were randomized in a 1:1 ratio to either the MICT group or HITT group (see Figure 1). To ensure the minimal effective dose of exercise, a minimum attendance rate was set based on previous research findings (Abreu et al., 2021). More specifically, participants who attended fewer than 70% of the training sessions were considered as dropouts. Adherence to the training program was closely monitored and consistently documented throughout the duration of the trial, enabling a thorough and ongoing analysis and assessment. In addition, health talks on dietary recommendations were conducted for all participants, which were based on the Dietary Guidelines for Chinese Residents, Version 2022 (Balanced Dietary Guidelines for Adolescents 14–17), for controlling overall the energy intake and the balance of various dietary categories. Training intervention Participants in both the MICT and HIIT groups engaged in treadmill training with varying intensity three times a week. Exercise intensity, duration, and heart rate (HR) were recorded during exercise, and adverse events that occurred during exercise were recorded. To reduce the risk of bias in the interpretation of our study results, an equalizing workload of training sessions would be used to match HIIT and MICT protocols. We used the following calculations (Isanejad et al., 2023): the average VO2peak of all participants before training was 2.68 L/min. The HIIT group completed 10 1‐min exercises at 2.41 L/min (90% of VO2peak) and 10 2‐min exercises at 1.6 L/min (60% of VO2peak). The total VO2 time relationship for the high‐intensity group was then divided by the intensity of the moderate‐intensity group (56.1 L/1.6 L/min = 35 min). All participants used HR monitor (Polar Electro, Kempele, Finland) during each training session. Thus, participants were able to control the corresponding exercise HR relative to VO2peak (see Figure 2). The protocol of exercise. HIIT group HIIT session consists of 5‐min warm‐up and cool‐down (50%–60% HRpeak) and 10 1‐min intervals at high intensity (85%–95% HRpeak) interspersed with 10 2‐min intervals at moderate exercise (60%–70% HRpeak) aiming for a Borg RPE scale rating of 16–17. A HR monitor was utilized to measure the training HR. Throughout the training sessions, the speed and incline of the treadmill were adjusted continuously to ensure that each session was carried out at the designated HR. MICT group Each MICT session comprised a 5‐min warm‐up and a 5‐min cool‐down phase (50%–60% HRpeak), with 35‐min moderate exercise (65%–75% HRpeak) in between. A HR monitor was utilized to measure the training HR. Throughout the training sessions, the speed and incline of the treadmill were adjusted continuously to ensure that each session was carried out at the designated HR. Measurements Blinded research assistants gathered baseline data and measurements from the participants, including their age, height, and weight. The primary outcome measure was change from baseline VO2peak. Secondary outcomes encompassed anthropometric parameters, brachial‐ankle pulse wave velocity (baPWV), and HR variability metrics (SDNN, RMSSD, HF, LF, TP, and LF/HF). Primary outcome Cardiopulmonary function The cardiopulmonary function of the participants was evaluated using the VO2000 system (Medical Graphics Corp.). VO2peak, which is regarded as the gold standard for assessing cardiopulmonary function, was determined (Yan et al., 2022). Ventilation indices and gas exchange analyses were determined by the VO2000 Gas Metabolism Analyzer (Medical Graphics Corp.), which was manually calibrated and completed before each test. The protocol was based on Libardi et al. [14] and consisted of a 2‐min warm‐up at 4 km/h, followed by an increase of 0.3 km/h every 30 s until physical exhaustion. The treadmill was set at a 1% incline during the test. The recovery period consisted of 4 min, starting at 5 km/h and reducing 1 km/h each minute. The peak VO2 value reached during an exercise test was defined as VO2peak. An exercise test was considered maximal if the following criteria were met (both of the following criteria were met): voluntary exhaustion; respiratory quotient greater than 1.1; and HR greater than 90% of the maximum HR; a plateau in oxygen uptake; Borg scale ≥17 ("ATS/ACCP Statement on cardiopulmonary exercise testing," 2003; Duft et al., 2022). Secondary outcomes Anthropometric parameters, BP and HR Anthropometric parameters, including weight and BMI, were assessed using the Seca 213 stadiometer (Seca). The BMI was calculated using the formula BMI = Body weight [kg]/Height2 [m2]. BMI is a widely utilized indicator for obesity and a risk factor for cardiovascular events in individuals with obesity. During the measurements, participants stood barefoot with their feet together and their backs parallel to the stadiometer. BP was measured using the Accoson sphygmomanometer (Accoson) three times after at least 5 min sitting position, and HR was measured using the Omron HEM 3 automated blood pressure machine (Omron). Flow‐mediated dilation The vascular endothelial function of participants was evaluated using FMD measurements conducted with the UNEX (unexp18g, UNEX, Japan) device. FMD is recognized as the gold standard for assessing the vascular endothelial function and is typically reduced in populations experiencing endothelial dysfunction (Harris et al., 2010). All participants were instructed to abstain from vigorous physical activity and certain dietary items (such as high‐nitrate foods, alcohol, and coffee) that could affect vasoreactivity before the test. FMD testing was administered by a highly experienced sonographer who was blinded to the experimental grouping. The FMD assessments took place in the afternoon, and the FMD of the right hand was evaluated with participants in a supine position and their arms secured on the testing table. The brachial artery, located 2–10 cm above the transverse elbow stripe, was selected as the test site, and each participant marked the test point (noted with a marker pen and photographed for record‐keeping). The test point was maintained in the same position until the subsequent evaluation. Once a clear ultrasound image of the vessel was obtained, the sensor head was immobilized to ensure the same scanning position. The cuff was released after at least 5 min of compression for each test, and the maximum vessel diameter was recorded during the last 2 min following compression. FMD was calculated using the formula: FMD = (arterial post‐congestive internal diameter—arterial basal internal diameter)/arterial basal internal diameter × 100%. Three measurements were obtained for each side, and the average value was used for analysis. Pulse wave velocity The vascular elasticity of the participants was evaluated using the brachial‐ankle baPWV measurement, which is a dependable indicator of vascular elasticity. Elevated baPWV readings indicate reduced vascular elasticity and an increased risk of atherosclerosis (Pereira et al., 2015). All participants were instructed to avoid vigorous physical activity and specific dietary items (including high‐nitrate foods, alcohol, and coffee) that could influence vasoreactivity before the test. The measurement of pulse wave velocity (PWV) was conducted by a highly experienced cardiologist who was blinded to the experimental groups. The test site was a constant‐temperature (22°C ± 2°C) and quiet test room, and prior to the measurements, the subjects were transported and trained to rest supine for at least 10 min in order to avoid the influence of physical activity on the test results after which four cuff sensors were attached to the humerus and ankle. The time interval (T) between the humeral wave front and the ankle wave front was calculated. The distance between the heart and the sampling point (L) was automatically calculated based on the height of the subject. BaPWV was calculated using the following formula: BaPWV = (La−Lb)/T, where "La" is the length from the heart to the ankle, and "Lb" is the length from the heart to the humerus. Three measurements were taken on each side, and the average value was used for analysis. Heart rate variability The cardiac autonomic function of the participants was assessed using heart rate variability (HRV) measurements obtained from Polar Electro in Kempele, Finland, which is considered the gold standard for evaluating cardiac autonomic function. HRV parameters included both time‐domain parameters (number of interval differences of adjacent RR intervals greater than 50 ms derived from differences between consecutive RR intervals [PNN50], root mean square of successive differences [RMSSD], standard deviation of NN intervals [SDNN]), and frequency‐domain parameters (total power, high frequency [HF], low frequency [LF], and low‐frequency/high‐frequency ratio [LF/HF]). These parameters can reflect sympathetic and vagal activity as well as the balance between the two with the LF/HF ratio considered a marker of sympathetic‐vagal balance. An increase in LF/HF suggests increased vagal activity, while a decrease suggests heightened sympathetic activity. All participants were instructed to avoid strenuous physical activity before the test. The HRV assessment was conducted by a highly experienced cardiologist who was unaware of the experimental groupings. Testing took place in the afternoon, and participants were prepared by ensuring they were in a relaxed state in a quiet environment. Polar devices were then placed on the chest to record electrocardiogram signals, which were continuously collected for 5 min while the participant remained still. Three measurements were taken, and the average value was used for analysis. Statistical analysis The main analysis adhered to the intention‐to‐treat principle. Baseline characteristics were compared using the t‐test for normally distributed variables and the Mann–Whitney U‐test for non‐normally distributed variables. The two‐way repeat analysis of variance was used to assess the impact of HIIT and MICT on study outcomes. In sensitivity analysis, the missing values in the HIIT group after the intervention were imputed using the latest available measurement data. The effect size (ES) was determined using partial eta‐squared (η 2 p) values (Lakens, 2013). According to Espirito Santo and Daniel (2018), η 2 p values ≥ 0.01 were considered small ES, η 2 p ≥ 0.06 indicated medium ES, and η 2 ≥ 0.14 represented large ES (Espirito Santo & Daniel, 2018). Data analysis was conducted using IBM SPSS Statistics for Windows, version 26.0 (IBM Corp.). Statistical significance was set at p < 0.05. RESULTS Participants' characteristics The participant flow is illustrated in Figure 1. Initially, 63 adolescent boys with obesity were assessed for eligibility, and 44 participants agreed to participate in the experiment. One boy withdrew consent and 43 (97.73%) completed the 8‐week exercise. Table 1 provides an overview of the participants' characteristics at baseline. Mean ± standard deviation (SD) values in all boys were 14 ± 1 years old for age, 31.6 ± 1.3 kg/m2 for BMI, and 33.16 ± 6.09 mL/kg/min for VO2peak. TABLE 1Baseline characteristics of obese adolescents stratified by the protocol.CharacteristicModerate‐intensity continuous training (n = 22)High‐intensity interval training (n = 22) p valueAge (years)14 ± 115 ± 10.002HR (bpm)77.50 (75.00–84.00)78.00 (75.75–84.00)0.555Height (m)1.59 ± 0.071.62 ± 0.080.122Weight (kg)78.33 ± 7.4484.20 ± 8.060.016BMI (kg/m2)31.1 ± 1.232.1 ± 1.20.076VO2peak (mL/kg/min)32.52 ± 6.6033.84 ± 5.450.476baPWV (m/s)878.18 ± 105.32909.09 ± 111.950.503FMD (%)7.05 ± 0.817.14 ± 0.960.748HRVPNN50 (ms)42.95 ± 20.8343.22 ± 20.430.966RMSSD (ms)64.85 (41.65–94.95)69.75 (52.90–90.38)0.481SDNN (ms)87.14 ± 38.5386.14 ± 41.230.934TP (ms2)3249.12 (2723.65–4053.86)3342.66 (2608.32–3869.29)0.589HF (ms2)1459.15 (1201.15–1862.42)1355.81 (1144.65–1637.56)0.542LF (ms2)1267.99 (1155.13–1540.03)1331.11 (1181.34–1466.98)0.542LF/HF0.95 (0.77–1.17)0.99 (0.92–1.04)0.488 Note: M (IQR) for non‐normally distributed data, M ± SD for normally distributed data.Abbreviations: 95%CI, 95% confidence interval; baPWV, brachial‐ankle pulse wave velocity; BMI, body mass index; FMD, flow‐mediated dilation; HF, high frequency; HR, heart rate; HRV, heart rate variability; LF/HF, low‐frequency/high‐frequency ratio; LF, low frequency; PNN50, number of interval differences of adjacent RR intervals greater than 50 ms derived from differences between consecutive RR intervals; RMSSD, root mean square of successive differences; SDNN, standard deviation of NN intervals; TP, total power; VO2peak, the peak oxygen consumption.*p < 0.05. Baseline characteristics of obese adolescents stratified by the protocol. Note: M (IQR) for non‐normally distributed data, M ± SD for normally distributed data. Abbreviations: 95%CI, 95% confidence interval; baPWV, brachial‐ankle pulse wave velocity; BMI, body mass index; FMD, flow‐mediated dilation; HF, high frequency; HR, heart rate; HRV, heart rate variability; LF/HF, low‐frequency/high‐frequency ratio; LF, low frequency; PNN50, number of interval differences of adjacent RR intervals greater than 50 ms derived from differences between consecutive RR intervals; RMSSD, root mean square of successive differences; SDNN, standard deviation of NN intervals; TP, total power; VO2peak, the peak oxygen consumption. *p < 0.05. Primary outcome Cardiopulmonary function After 8 weeks of intervention, both the MICT group and the HIIT group exhibited a significant improvement in VO2peak. The mean and SD change from baseline was 3.49 ± 1.53 mL/kg/min (p < 0.001) for the MICT group and 4.43 ± 3.38 mL/kg/min (p < 0.001) for the HIIT group. No statistically significant difference was found between the HIIT and MICT group (F = 1.404, p = 0.243, Partial η 2 = 0.033; see Table 2). TABLE 2Primary and secondary outcomes of the obese adolescents after HIIT or MICT.OutcomeModerate‐intensity continuous training (MICT)High‐intensity interval training (HIIT)GroupTimeGroup×TimeBaselineInterventionBaselineInterventionFPa Partial η 2 FPb Partial η 2 FPc Partial η 2 (n = 22)(n = 22)(n = 22)(n = 22)Primary outcomeVO2peak (mL/kg/min)32.52 ± 6.6036.01 ± 6.8933.84 ± 5.4538.26 ± 5.620.9210.3430.02299.479<0.0010.7081.4040.2430.033Secondary outcomesWeight (kg)78.33 ± 7.4476.80 ± 7.5084.20 ± 8.0682.29 ± 8.085.7050.0220.122115.444<0.0010.7381.4850.2300.035BMI (kg/m2)31.1 ± 1.230.1 ± 1.332.1 ± 1.231.0 ± 1.35.7790.0210.124307.283<0.0010.8821.0210.3180.024baPWV (m/s)878.18 ± 105.32853.59 ± 95.11909.09 ± 111.95882.62 ± 92.820.9530.3350.02335.911<0.0010.4670.0730.7890.002FMD (%)7.05 ± 0.817.31 ± 0.917.14 ± 0.968.28 ± 1.083.7040.0610.08350.244<0.0010.55120.224<0.0010.330HRVPNN50 (ms)42.95 ± 20.8348.99 ± 20.2143.22 ± 20.4348.90 ± 19.760.0000.9940.000122.433<0.0010.7490.0680.7950.002RMSSD (ms)64.85 (41.65–94.95)67.70 (46.10–104.18)69.75 (52.90–90.38)74.30 (58.75–100.55)0.1220.7280.00319.095<0.0010.3181.9030.1750.044SDNN (ms)87.14 ± 38.5396.05 ± 36.6186.14 ± 41.2397.62 ± 39.080.0010.9760.00040.304<0.0010.4960.5780.4510.014TP (ms2)3249.12 (2723.65–4053.86)3656.33 (3192.07–4061.65)3342.66 (2608.32–3869.29)3441.32 (2744.08–4270.31)0.0990.7550.0028.3060.0060.1680.3810.5410.009HF (ms2)1459.15 (1201.15–1862.42)1782.65 (1477.65–2173.17)1355.81 (1144.65–1637.56)1874.73 (1679.58–2159.65)0.1600.6910.004140.888<0.0010.7757.5270.0090.155LF (ms2)1267.99 (1155.13–1540.03)1586.27 (1352.84–1897.90)1331.11 (1181.34–1466.98)1512.34 (1437.79–1774.11)0.0820.7760.002106.689<0.0010.7220.0500.8250.001LF/HF0.95 (0.77–1.17)0.93 (0.79–1.20)0.99 (0.92–1.04)0.85 (0.75–0.98)0.7270.3990.01719.514<0.0010.3224.7400.0350.104 Note: M(IQR) for non‐normally distributed data, M ± SD for normally distributed data. Pa values are for pre‐post‐intervention group effect; Pb values are for pre‐post‐intervention time effect; Pc values are for the interaction between time and the group. Values of Partial η 2 ≥ 0.01 were considered small ES, Partial η 2 ≥ 0.06 were considered medium ES, and Partial η 2 ≥ 0.14 was considered large ES.Abbreviations: 95%CI, 95% confidence interval; baPWV, brachial‐ankle pulse wave velocity; BMI, body mass index; BMI, body mass index; FMD, flow‐mediated dilation; HF, high frequency; HRV, heart rate variability; LF/HF, low frequency/high frequency ratio; LF, low frequency; PNN50, number of interval differences of adjacent RR intervals greater than 50 ms derived from differences between consecutive RR intervals; RMSSD, root mean square of successive differences; SDNN, standard deviation of NN intervals; TP, total power; VO2peak, the peak oxygen consumption.*p < 0.05. Primary and secondary outcomes of the obese adolescents after HIIT or MICT. Note: M(IQR) for non‐normally distributed data, M ± SD for normally distributed data. Pa values are for pre‐post‐intervention group effect; Pb values are for pre‐post‐intervention time effect; Pc values are for the interaction between time and the group. Values of Partial η 2 ≥ 0.01 were considered small ES, Partial η 2 ≥ 0.06 were considered medium ES, and Partial η 2 ≥ 0.14 was considered large ES. Abbreviations: 95%CI, 95% confidence interval; baPWV, brachial‐ankle pulse wave velocity; BMI, body mass index; BMI, body mass index; FMD, flow‐mediated dilation; HF, high frequency; HRV, heart rate variability; LF/HF, low frequency/high frequency ratio; LF, low frequency; PNN50, number of interval differences of adjacent RR intervals greater than 50 ms derived from differences between consecutive RR intervals; RMSSD, root mean square of successive differences; SDNN, standard deviation of NN intervals; TP, total power; VO2peak, the peak oxygen consumption. *p < 0.05. Secondary outcome Anthropometric parameters After 8 weeks exercise, both the MICT and HIIT groups showed significant decreases in weight. The mean and SD change from baseline was −1.53 ± 0.95 kg (p < 0.001) for weight in the MICT group and −1.92 ± 1.15 kg (p < 0.001) in the HIIT group. Similarly, there were significant reductions in BMI in both groups with the mean and SD change values in BMI being −1.0 ± 0.4 kg/m2 (p < 0.001) for the MICT group and −1.1 ± 0.4 kg/m2 (p < 0.001) for the HIIT group. The changes in weight (F = 1.485, p = 0.230, Partial η 2 = 0.035) and BMI (F = 1.021, p = 0.318, Partial η 2 = 0.024) did not significantly differ between the two groups (see Table 2). Pulse wave velocity After 8 weeks of exercise, both the MICT and HIIT groups exhibited significant decreases in baPWV values. The mean and SD change in baPWV was −24.59 ± 25.55 m/s (p < 0.001) for the MICT group and −26.90 ± 30.68 m/s (p = 0.001) for the HIIT group. There was no significant difference between the groups (F = 0.073, p = 0.789, Partial η 2 = 0.002; see Table 2). Flow‐mediated dilation After 8 weeks of exercise, both the MICT and HIIT groups showed significant increases in FMD%. The mean and SD change in FMD% for the MICT group was 0.25 ± 0.46% (p = 0.017), while for the HIIT group, it was 1.14 ± 0.79% (p < 0.001). Importantly, the change in FMD% was significantly higher in the HIIT group compared to the MICT group (F = 20.224, p < 0.001, Partial η 2 = 0.330; see Table 2). Heart rate variability After 8 weeks of exercise, the change in HF was significantly higher in the HIIT group compared to the MICT group (F = 7.527, p = 0.009, Partial η 2 = 0.155). Similarly, the change in LF/HF was significantly higher in the HIIT group compared to the MICT group (F = 4.740, p = 0.035, Partial η 2 = 0.104). There were no significant differences in the changes in PNN50(F = 0.068, p = 0.795, Partial η 2 = 0.002), RMSSD (F = 1.903, p = 0.175, Partial η 2 = 0.044), SDNN (F = 0.578, p = 0.451, Partial η 2 = 0.014), TP (F = 0.381, p = 0.541, Partial η 2 = 0.009), and LF (F = 0.050, p = 0.825, Partial η 2 = 0.001) between the HIIT and MICT groups (see Table 2). Sensitivity analysis Sensitivity analysis by using impute missing data of the latest available measurement data showed consistent result in Table S1. Adverse outcome There were no adverse events both in the HIIT and MICT groups. DISCUSSION Major findings The aim of this study was to compare the HIIT and MICT in cardiopulmonary function, cardiac autonomic function, vascular function (endothelial function and vascular elasticity) and weight control in adolescent with obesity. The results revealed that HIIT outperformed MICT in enhancing endothelial function and certain HRV parameters (HF and LF/HF) in adolescents with obesity. However, there were no significant differences between HIIT and MICT in terms of VO2peak, baPWV, certain HRV parameters (PNN50, RMSSD, SDNN, TP, LF), weight, and BMI. These findings suggest that HIIT may offer unique benefits for improving endothelial function and specific aspects of cardiac autonomic function compared to MICT in adolescent boys with obesity. Comparison with previous studies Cardiorespiratory function improvement Recent research has highlighted the concerning cardiovascular risks associated with adolescent obesity, including significant issues like cardiac autonomic dysfunction, endothelial dysfunction, decreased arterial compliance, and compromised cardiopulmonary function, all of which escalate the risk of future cardiovascular complications (Cozzolino et al., 2014; Dangardt et al., 2013; McGavock et al., 2009). MICT has been strongly linked to cardiovascular health, offering protective benefits through diverse physiological mechanisms (Alberga et al., 2016; Chen et al., 2016; Watts et al., 2004). Concurrently, HIIT has emerged as an appealing, time‐efficient alternative to MICT, showcasing comparable or superior cardiovascular advantages (Cao et al., 2021; Keteyian et al., 2014). The primary cardiovascular benefits of both HIIT and MICT stem from their ability to enhance cardiorespiratory function. Our study demonstrated that both HIIT and MICT significantly improved cardiopulmonary function, measured as VO2peak, in adolescent boys with obesity. Cardiorespiratory function, specifically VO2peak, is a well‐established predictor of cardiovascular disease and all‐cause mortality (Lee et al., 2011). Consequently, the enhancements observed in cardiorespiratory function due to HIIT and MICT suggest a substantial reduction in the future cardiovascular disease and mortality risk within this population. Essentially, adaptive changes in the cardiorespiratory system in response to increased metabolic demands mediated by prolonged exercise are the primary physiologic mechanism by which exercise improves cardiorespiratory function. Differences in clinical benefits resulting from differences in endogenous stimuli mediated by exercise intensity and duration and their interactions are central to clinical exercise physiology. Therefore, the primary factor when comparing HIIT and MICT is to match the energy of the exercise model to provide an equal amount of endogenous stimulation, and although energy expenditure during exercise is matched equally, HIIT tends to mediate a more sustained post‐exercise excess oxygen consumption due to its higher exercise intervals. Interestingly, our study did not find a significant disparity between HIIT and MICT concerning improvements in VO2peak among adolescent boys with obesity. Our results were consistent with the previous study on exercise interventions for cardiorespiratory function in adolescents with obesity, where HIIT did not show superior results to MICT for VO2peak [37]. Common to the study and our results is that HIIT was set at a low dose (≤60s), so the amount of endogenous stimulation from low‐volume HIIT may not be sufficient to induce the significant results of improved VO2peak compared with an equivalent amount of MICT (Fisher et al., 2015; Lazzer et al., 2017). Accordingly, we hypothesized that the shorter high‐intensity intervals of low‐volume HIIT triggered insufficient post‐exercise oxygen consumption to differentiate from matched isoenergetic MICT. In addition, these discrepancies could also be attributed to factors such as participant age and obesity levels. However, our findings indicate that for enhancing cardiorespiratory function, HIIT might be more suitable for adolescents with obesity due to its time efficiency. Cardiac autonomic function The cardiovascular benefits of both HIIT and MICT also extend to the improvement of cardiac autonomic function. A meta‐analysis has affirmed that long‐term exercise provides substantial benefits for enhancing cardiac autonomic function in adolescents with obesity. It achieves this by boosting vagal tone and balancing the sympathetic‐vagal axis (Dias et al., 2021). In our study involving adolescent boys with obesity, we observed improvements in autonomic function with both MICT and HIIT. However, HIIT stood out by inducing more significant vagal activation and a better balance between sympathetic and vagal tension. This finding is consistent with results obtained in children with obesity (van Biljon et al., 2018). However, a recent study showed no significant difference in dynamic HR variability after acute HIIT and MICT exercise in young men with obesity (Van Gaal et al., 2006). The differential result between acute and chronic exercise is a manifestation of cardiac autonomic function adapting to exercise, with chronic exercise acting as a cumulative of acute exercise, synthesizing the effective physiological stimuli of acute exercise, and leading to adaptations in cardiac autonomic function. The amplified enhancement in cardiac autonomic function achieved through HIIT can be attributed to a more extensive range of hemodynamic and cardiometabolic regulatory effects. These, in combination with β‐adrenergic responses, trigger adaptations and modulation of cardiac autonomic function in response to the wide array of physiological challenges posed by exercise (MartinezAguirre‐Betolaza et al., 2020; Racil et al., 2016; Rodrigues et al., 2020). The modulation of cardiac autonomic function is a complex process influenced by the intricate network of cardiovascular centers. Our current knowledge does not reveal whether HIIT and MICT impact this network differently, potentially leading to varying adjustments in sympathetic and vagal outflow and tone. These variations might translate into differences in HRV performance. Our results highlight the potential to enhance cardiac autonomic function in adolescents with obesity (Dias et al., 2022). Vascular function Obesity‐induced vascular dysfunction is a significant independent risk factor for an elevated risk of cardiovascular disease (CVD) in adulthood, characterized by endothelial dysfunction and decreased vascular elasticity (Kim et al., 2015). Exercise, as a non‐pharmacological intervention, has the potential to provide substantial benefits for vascular function. A meta‐analysis has underscored that HIIT is more effective than MICT in enhancing FMD, and this may be due to HIIT's superiority in addressing traditional CVD risk factors, oxidative stress, inflammation, and insulin sensitivity (Ramos et al., 2015). Our study has validated that both HIIT and MICT bring about improvements in endothelial function and vascular elasticity in adolescents with obesity. However, HIIT appears to offer a more substantial advantage in enhancing endothelial function. This HIIT‐induced improvement in endothelial function has also been corroborated in studies involving obese adults (Sawyer et al., 2016). In addition to traditional cardiovascular risk factors and their modulation, exercise‐induced blood flow shear has been suggested as a primary mechanism for the enhancement of endothelial function. Research has affirmed that HIIT generates more favorable blood flow shear patterns compared to MICT, which may account for the superior improvement in endothelial function (Ghardashi Afousi et al., 2018; Shi et al., 2022). Notably, evidence derived from studies involving obese children and obese adults indicates that HIIT surpasses MICT in improving PWV, a marker of vascular stiffness. This difference could be attributed to HIIT's effects on anti‐inflammatory responses and lipid metabolism (Paahoo et al., 2021; Soltani et al., 2021). The observed disparities in PWV effects may also relate to variations in the intervention period. Our study employed an 8‐week intervention period, whereas the mentioned study utilized a 12‐week intervention (Chuensiri et al., 2018). Clinical implication In summary, our study revealed that both HIIT and MICT produced improvements in cardiopulmonary function, cardiac autonomic function, and vascular function in adolescents with obesity. Moreover, HIIT was superior in enhancing vascular endothelial function and the balance between the vagal and sympathetic nervous systems compared to MICT. As previously shown, HIIT's shorter time requirement may enhance adherence among adolescents with obesity. Finally, in terms of weight control, both 8 weeks of low‐volume HIIT and the equal‐workload MICT, in conjunction with dietary recommendations, could reduce body weight and BMI in adolescents with obesity. However, it is worth noting that neither exercise could reduce obese adolescents to overweight levels. This suggests that low‐dose short‐term exercise interventions and dietary recommendations alone may be insufficient to reduce obesity levels to overweight in the absence of strict dietary restrictions and that more extended exercise programs and strict dietary interventions might be necessary to achieve better weight management. Limitations This trial has certain limitations that should be acknowledged. First, our study only included male participants, and our findings may not be generalizable to other sex due to the physiological differences between males and females. Second, the study participants were of Asian ethnicity, and our results may not apply to other regions and countries with different demographic and genetic backgrounds. Third, we did not conduct biomarker analyses for metabolic and cardiovascular factors that could further elucidate our findings. Finally, based on pre‐camp experience, obese adolescents had difficulty adhering to the high‐volume HIIT program when executing it, so a low‐volume HIIT program was executed in this study, taking into account factors such as exercise risk and physical fitness. In addition, based on the requirements of the exercise guidelines, the HIIT model was performed three times per week, so the matched MICT model was also performed 3 times per week, and the total duration of exercise for both did not reach the recommended threshold of the physical activity guidelines (150 min per week). CONCLUSIONS Eight weeks HIIT and MICT had similar effects on improving cardiopulmonary function, vascular elasticity, body weight, and BMI in adolescent boys with obesity. However, HIIT intervention proved to be highly effective in enhancing endothelial function and vago‐sympathetic balance compared to MICT. CONFLICT OF INTEREST STATEMENT The authors have no conflict of interests to declare. PATIENT CONSENT STATEMENT The participants provided their written informed consent to participate in this study. PERMISSION TO REPRODUCE MATERIAL FROM OTHER SOURCES All materials in this paper are original and no content or materials from other sources have been used. All figures, data, and references are created by the author or compiled from public domain sources. CLINICAL TRIAL REGISTRATION Chinese Clinical Trial Registry, ChiCTR2300070813. Registered April September 24, 2023, https://www.chictr.org.cn/showproj.html?proj=195685. Supporting information Table S1